BridgeMD
New treatment option for Cancer
Official title Acupuncture for People Experiencing Period Loss Due to Chemotherapy
ClinicalTrials.gov ID: NCT06915116
What this study is testing
- What it's testing
- The purpose of this study is to find out whether it is practical (feasible) to use acupuncture to treat period loss (amenorrhea) caused by chemotherapy treatment in people with cancer. The researchers will look at how many participants enroll and complete the study.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 40, women only
You may be able to join if
- English speaking woman between the ages of 15 and 40
- History of stage I, II, or III cancer OR stage IV or unstaged hematologic malignancy (e.g. lymphoma, leukemia, myeloma) that is stable, as assessed...
- Premenopausal status with regular menstruation at the time of diagnosis by patient report
- Completed cytotoxic chemotherapy within the past year
- Premenopausal status with regular menstruation at the time of diagnosis by patient report for females ages 18 or older
You likely can't join if
- Had been pregnant or lactating within 3 months prior to enrollment
- History of hysterectomy or bilateral oophorectomy
- Ongoing or planned radiation or surgery within 4 months from randomization
- Use of acupuncture for menses recovery within 3 months of enrollment
- Had been or will be receiving ovarian suppression medicine, such as leuprolide (Lupron) and goserelin (Zoladex), or hormonal contraception drugs...
See the full eligibility criteria
- English speaking woman between the ages of 15 and 40
- History of stage I, II, or III cancer OR stage IV or unstaged hematologic malignancy (e.g. lymphoma, leukemia, myeloma) that is stable, as assessed by care team
- Premenopausal status with regular menstruation at the time of diagnosis by patient report
- Completed cytotoxic chemotherapy within the past year
- Premenopausal status with regular menstruation at the time of diagnosis by patient report for females ages 18 or older
- Report cessation of menses during or after chemotherapy and have not experienced menses recovery at the time of enrollment.
- Have reached menarche prior to therapy or during therapy for females between 15 and 17 years old
- Patient reports cessation of menses during or after chemotherapy and have not experienced menses recovery at the time of enrollment.
- Have been without menses for at least 3 months 64 following the completion of cytotoxic chemotherapy
- Willing to adhere to all study-related procedures, including randomization to one of the two possible arms: acupuncture and WLC
- Had been pregnant or lactating within 3 months prior to enrollment
- History of hysterectomy or bilateral oophorectomy
- Ongoing or planned radiation or surgery within 4 months from randomization
- Use of acupuncture for menses recovery within 3 months of enrollment
- Had been or will be receiving ovarian suppression medicine, such as leuprolide (Lupron) and goserelin (Zoladex), or hormonal contraception drugs within 3 months of enrollment or during the study period
The study team makes the final eligibility decision.
Where it's taking place
- Basking Ridge, New Jersey, United States
- Middletown, New Jersey, United States
- Montvale, New Jersey, United States
- Commack, New York, United States
- Harrison, New York, United States
- New York, New York, United States
- Rockville Centre, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 15 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Basking Ridge, New Jersey, United States; Middletown, New Jersey, United States; Montvale, New Jersey, United States; Commack, New York, United States; Harrison, New York, United States; New York, New York, United States and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.